In this regard, our analysis of clinical melanoma samples, that express high levels of HIF-1α, reveals that ETBR activation is associated with a reduction of PHD2, further supporting that ETBR-mediated PHD2 downregulation represents a pathway for HIF-1α activation in human melanomas. The gene discussed is HIF1A; the disease is melanoma.